Project Grant R21NS130427

Award Date 8/11/23
Completion Date 7/31/25
Dollars Obligated $437K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $571,404 to the University of Pittsburgh to conduct research on the use of the adipokine adiponectin as a potential therapeutic for improving neurological outcomes and cognitive recovery after traumatic brain injury (TBI). The key objectives are to: 1) evaluate the long-term...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $628,133 Project Grant (CFDA 93.853) to Rutgers, The State University to study the "Metabolic Mechanisms of Recovery in Mild TBI" from September 1, 2024 to July 31, 2028. The research aims to determine if activating the CYPIN protein can promote functional recovery after mild traumatic brain injury (TBI) in mice. This builds on previous work identifying CYPIN as a key molecule regulating methionine levels and...
The University of Pittsburgh was awarded a $1,306,281 Project Grant under the Department of the Army's Military Medical Research and Development program (CFDA 12.420) to conduct the "MITOCHONDRIAL INFLAMMATORY SYNAPTIC SYSTEMS IMAGING OF NEUROINJURY (MISSION) FOR MILD REPETITIVE TRAUMATIC BRAIN INJURY" research project. The award began on July 1, 2024 and is scheduled for completion on June 30, 2028. The project aims to study the mechanisms of mitochondrial inflammation and synaptic...
The National Institute on Aging (NIA) awarded a $3,770,822 Project Grant under the Aging Research program (CFDA 93.866) to the University of Pittsburgh. The grant aims to investigate the relationship between epigenetic aging and patient outcomes after severe traumatic brain injury (TBI). Key objectives include determining if accelerated epigenetic aging is linked to variation in acute and long-term outcomes up to 2 years after severe TBI, and exploring how social determinants of health impact...
This $1,526,245 Project Grant awarded on July 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund the "MITOCHONDRIAL INFLAMMATION SYNAPTIC SYSTEMS IMAGING OF NEUROINJURY (MISSION) FOR MILD REPETITIVE TRAUMATIC BRAIN INJURY" research project at the University of Pittsburgh. The project aims to investigate mechanisms and treatments for mild, repetitive traumatic brain injury through research on mitochondrial...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $102,948.00 to Case Western Reserve University to investigate the link between traumatic brain injury (TBI), hematopoietic stem cell dysfunction, chronic neurodegeneration, and Alzheimer's disease (AD). The key objectives are to assess how acute TBI induces changes to...
This $3,109,079 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research at the University of California, Riverside to investigate the role of traumatic brain injury (TBI) across the lifespan in the development of Alzheimer's disease and related dementias (ADRD). The project will use a closed head injury (CHI) TBI mouse model to examine how ADRD risk factors, such as the APOE4 gene and amyloid-beta, interact with TBI at different life stages...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will fund research at the Augusta University Research Institute, Inc. (doing business as Georgia Health Sciences) to investigate the mechanisms linking traumatic brain injury (TBI) to subsequent neurodegeneration and dementia. The $1,975,262 award will support a 3-year study...
This Project Grant award, with a total funding amount of $453,860.00, was issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award supports research aimed at understanding the role of metabolic regulation, particularly AMPK activation, in modulating neutrophil extracellular trap (NET) formation and inflammation following traumatic brain injury...
The federal Project Grant award R01NS134799, totaling $404,100.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research to investigate the cellular and molecular mechanisms underlying chronic blood-brain barrier (BBB) dysfunction after traumatic brain injury (TBI). The research aims to identify an endothelial RIPK1-RIPK3-IL-1β...

The University of Pittsburgh is receiving a $437,250 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant aims to provide proof-of-concept evidence that retinoic acid (RA) can attenuate cholinergic deficits and white matter connectivity impairments after traumatic brain injury (TBI). The two-year project will: 1) determine if RA treatment can preserve key cholinergic proteins critical for acetylcholine neurotransmission after TBI, and 2) examine the effects of TBI and RA therapy on cholinergic-associated white matter tracts using high-definition fiber tractography. If successful, the research could demonstrate the therapeutic potential of RA to combat cognitive deficits following TBI by targeting neurochemical and structural brain changes.

Generated 7/16/24, 2:09 AM